Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Más de 100 expertos en terapia celular y génica reunidos en Colonia con motivo del 25º aniversario de Cellex

      • USA - English
      • USA - Français
      • USA - Deutsch
      • USA - English
      Cellex Cell Professionals GmbH Logo

      News provided by

      Cellex Cell Professionals GmbH

      Nov 17, 2026, 08:00 ET

      Share this article

      Share this article


      COLONIA, Alemania, 17 de noviembre de 2026 /PRNewswire/ -- Cellex Cell Professionals recibió a más de 100 investigadores, clínicos y expertos del sector en el Simposio Cellex 2026, celebrado el 8 de noviembre en el hotel Wasserturm de Colonia. Bajo el lema "La terapia celular y génica, en un punto de inflexion", el evento incluyó 10 presentaciones científicas distribuidas en tres sesiones, que abarcaron todo el proceso, desde la investigación y el desarrollo hasta la comercialización a escala global.

      Continue Reading
      Cellex Symposium 2026 "Cell and Gene Therapy at a Turning Point"
      Cellex Symposium 2026 "Cell and Gene Therapy at a Turning Point"

      El simposio también marcó el 25º aniversario de Cellex, que ha pasado de ser un proveedor de servicios de aféresis para registros de donantes de células madre a convertirse en una organización de desarrollo y fabricación por contrato (CDMO) en el ámbito de la terapia celular.

      La sesión inaugural, titulada "Traducción: de las células al impacto clínico", se centró en la traslación de las terapias celulares a la práctica clínica. Se abordaron temas como las células T modificadas genéticamente, la terapia con células inmunitarias alogénicas para el tratamiento de la sepsis, y el cumplimiento de las normas de correcta fabricación (GMP) como factor determinante del rendimiento en la producción. En esta sesión participaron los doctores Hyatt Balke-Want (Hospital Universitario de Colonia), Jens Altrichter (Artcline GmbH) y Matthias Domogalla (Cellex). La segunda sesión, centrada en el "abordaje terapéutico", trató sobre cánceres y trastornos genéticos de difícil tratamiento; se analizaron desde vacunas peptídicas y plataformas de edición genética hasta células T con receptores de antígenos (TCR) dirigidas contra el antígeno PRAME, así como antígenos de difícil diana en tumores sólidos y neoplasias hematológicas. Los ponentes fueron los profesores Elke Jäger (Hospital North-West de Frankfurt), Frank Buchholz (Universidad Técnica de Dresde) y Martin Wermke (Hospital Universitario de Dresde), junto con el doctor Ali Mohammed (Immatics Biotechnologies).

      En mesas de expertos moderadas, los participantes debatieron sobre la inteligencia artificial en un entorno regulado y sobre si es posible mantener la calidad del producto en diferentes centros de fabricación. La sesión de clausura, titulada "Realidad del mercado", se centró en el escalado —abordando temas como las materias primas bajo normas GMP, los modelos integrados de CDMO y el papel de China en el sector biotecnológico global—, con intervenciones de Rachel Atlee (Akron Bio), la doctora Suvi Annala (Cellex) y Ping Shek (STBio Limited).

      "Un excelente encuentro para volver a conectar con amigos y colaboradores en el campo de la terapia celular y génica", señaló el profesor y doctor en medicina Martin Wermke, director de la Unidad de Ensayos Clínicos Tempranos del Centro Nacional de Enfermedades Tumorales de Dresde. "En una sola jornada, el simposio abarcó todo el recorrido, desde la investigación y el desarrollo hasta la comercialización. El intercambio abierto entre el ámbito académico y la industria puso de manifiesto que las decisiones que tomemos hoy en nuestro campo determinarán la próxima década".

      "Las terapias avanzadas solo llegarán a los pacientes a gran escala si la ciencia, la fabricación y la experiencia en materia regulatoria avanzan de la mano", afirmó el doctor Armin Ehninger, director científico y estratégico de Cellex Cell Professionals. "Este simposio reunió todas estas perspectivas en un mismo espacio, y esperamos continuar con estas conversaciones junto a nuestros socios".

      Acerca de Cellex Cell Professionals

      Fundada hace 25 años para prestar servicios de aféresis a registros de donantes de células madre, Cellex Cell Professionals es hoy una CDMO (organización de desarrollo y fabricación por contrato) especializada en terapia celular, con más de 10 años de experiencia en la fabricación de productos autólogos y alogénicos. La empresa brinda apoyo a socios del sector farmacéutico, biotecnológico y académico a lo largo de las etapas de desarrollo preclínico y clínico, así como en la fabricación comercial. Cellex combina su experiencia en fabricación bajo normas GMP con la obtención de materiales celulares de partida y capacidades de gestión de la cadena de suministro.

      Aprenda más: www.cellex.me/en

      Contacto de Prensa: 
      Elena Görris
      Directora de Marketing Estratégico  
      Cellex Cell Professionals GmbH
      E-mail: [email protected] 
      Tel: +49 151 12410817

      Modal title

      Also from this source

      100+ Cell and Gene Therapy Experts Meet in Cologne as Cellex Marks 25 Years

      100+ Cell and Gene Therapy Experts Meet in Cologne as Cellex Marks 25 Years

      Cellex Cell Professionals welcomed more than 100 researchers, clinicians and industry experts to the Cellex Symposium 2026 on November 8 at the...

      Mehr als 100 Experten für Zell- und Gentherapie treffen sich in Köln anlässlich des 25-jährigen Jubiläums der Cellex

      Mehr als 100 Experten für Zell- und Gentherapie treffen sich in Köln anlässlich des 25-jährigen Jubiläums der Cellex

      Cellex Cell Professionals begrüßte am 8. November mehr als 100 Forscher, Kliniker und Branchenexperten zum Cellex Symposium 2026 im Wasserturm Hotel...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Biotechnology

      Biotechnology

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.